Latest by Kenyon Farrow
"A lot of patients want to know, 'Who else is going to see this data?'" said Peter Chai of Fenway Health in Boston.
The US Preventive Services Task Force released its final ruling in JAMA.
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.
The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.
Richard Jefferys, an expert in HIV cure research, spoke to TheBodyPro about this new case of HIV remission -- and the danger in rushing to publish these stories, especially for people who live with stigma.
After years of anecdotes and speculation, harm reduction and pharma watchdog advocates have data to back claims that the spike in opioid deaths in the U.S. can be tied to pharmaceutical companies marketing highly addictive opioids to doctors.
Four researchers at the HIV Research for Prevention Conference (HIVR4P) presented their work to develop safe and effective anal/vaginal douches and inserts, implantables that are biodegradable, and vaginal rings.
Despite their increased risk, only one-third of adolescents and young adults with known opioid use disorder were screened for hepatitis C, according to a study released at the IDWeek conference in San Francisco.
At USCA 2018, Black Lives Matter Cofounder Alicia Garza Discusses HIV and Building Black Social Justice Power
Alicia Garza talks with TheBodyPRO's Kenyon Farrow about HIV's relative invisibility in black social justice spaces, despite its disproportionate impact on black communities.